Amy M. Scurlock

High Impact

Professor

UAMS

Last publication 2025 Last refreshed 2026-05-16

faculty

Peds Pediatrics, College of Medicine

35 h-index 158 pubs 7,026 cited

Research Areas

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Amy M. Scurlock is a Professor of Pediatrics at the University of Arkansas for Medical Sciences (UAMS) and Arkansas Children’s Hospital (ACH) and Research Institute. Her clinical work involves caring for patients with a range of allergic and immunologic conditions, with specific interests in food allergy and primary immunodeficiency. She emphasizes patient- and family-centered care, integrating evidence-based management with consideration for social determinants of health.

Dr. Scurlock's research focuses on clinical trials in food allergy and eosinophilic gastrointestinal disorders, supported by federal, foundation, and industry funding. She is actively involved in the Food Allergy Research and Education (FARE) Clinical Network and FARE Neighborhoods Program, and serves as a Steering Committee member for the NIAID Consortium of Food Allergy Research (CoFAR). Her research interests also extend to evaluating mucosal immune responses in models of food allergy and eosinophilic gastrointestinal disorders. She has authored or co-authored 158 publications and has an h-index of 35, with 6,953 citations. Her work is recognized as high-impact, evidenced by her highly cited status.

Research Overview

Amy M. Scurlock, M.D. is an Associate Professor of Pediatrics at the University of Arkansas for Medical Sciences and Arkansas Children's Hospital. Dr. Scurlock is also a researcher at Arkansas Children's Hospital Research Institute. Dr. Scurlock received her M.D. in 1998 from the University of Arkansas for Medical Sciences. She completed a residency in Pediatrics at UAMS/ACH in 2001 and served as Chief Resident until 2002. She completed her Allergy-Immunology Fellowship Training at Duke University Medical Center in Durham North Carolina in 2004. Dr. Scurlock joined the UAMS faculty in August 2004 as a member of the Division of Pediatric Allergy/Immunology within the Department of Pediatrics. Dr. Scurlock's clinical interests include allergic and immunologic diseases such as food allergy, atopic dermatitis, eosinophilic esophagitis and primary immunodeficiency. She also has interest in newborn screening and long-term follow-up for infants with SCID and T-cell lymphopenia. Her research interests are focused on evaluation of mucosal immune responses in models of food allergy and eosinophilic gastrointestinal disorders. Dr. Scurlock is a member of the American Academy of Allergy Asthma and Immunology (AAAAI), Society for Mucosal Immunology, Society for Pediatric Research, Clinical Immunology Society, and American Academy of Pediatrics. She is board certified in both Pediatrics and Allergy-Immunology. Some of the UAMS College of Medicine faculty members provide pediatric patient care at Arkansas Children's Hospital. In addition, a wide range of pediatric services are provided in more than 35 subspecialties around Arkansas in locations such as the Schmieding Developmental Center in Springdale and the James L. Dennis Developmental Center in Little Rock. To make an appointment at Arkansas Children's Hospital, please call 501-364-4000.

Metrics

h-index: 35
Publications: 158
Citations: 7,026

Selected Publications

Implementation of early peanut introduction among providers in a southern US state (2026)

DOI OpenAlex
Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies (2025)

DOI OpenAlex
Introduction of allergenic foods after treatment with omalizumab (2025)

7 citations DOI OpenAlex
Introduction Of Allergenic Foods After Treatment With Omalizumab (2025)

DOI OpenAlex
Multicenter food protein–induced enterocolitis syndrome (FPIES) data collection: Leveraging a REDCap FPIES registry for improved clinical outcomes (2025)

1 citation DOI OpenAlex
Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent (2024)

34 citations DOI OpenAlex
Long-term walnut oral immunotherapy induces shifts in serum antibody binding patterns to walnut and cross-reactive tree nuts (2024)

DOI OpenAlex
Long-Term Follow-up after IMPACT Peanut Oral Immunotherapy Clinical Trial (2024)

1 citation DOI OpenAlex
Survey of Arkansas Pediatric Providers on the Application of the NIH/NIAID Addendum Guidelines for the Prevention of Peanut Allergy in the United States (2024)

DOI OpenAlex
Food insecurity and allergic diseases: A call to collective action (2023)

9 citations DOI OpenAlex
Peanut allergy (2023)

DOI OpenAlex
The SunBEAm birth cohort: Protocol design (2023)

9 citations DOI OpenAlex
Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy (2023)

29 citations DOI OpenAlex
Efficacy and Safety of Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in Subjects Aged 1-3 Years With and Without Atopic Dermatitis in the EPITOPE Study (2023)

3 citations DOI OpenAlex
Food insecurity in children and adults with food allergies (2022)

37 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

FARE Network UAMS ACHRI Flow Through Principal Investigator
Immunoregulatory Networks in Chlamydia Genital Tract Infection NIH Principal Investigator
No FP attached UAMS ACHRI Flow Through Principal Investigator
FARE Network UAMS ACHRI Flow Through Principal Investigator
No FP attached UAMS ACHRI Flow Through Principal Investigator